If you have read previous articles here on Macroaxis, then you will likely know that pharmaceutical stocks or any drug creating stocks can be volatile, with today proving that point. When the FDA decides to reject a product, it essentially costs the company hundreds of millions of dollars because they put so much time and energy into research and development, as well as experimentations. So when that happens, you can see a stock drop dramatically out of the sky, causing long term investors to worry because they are not looking for the volatility. [more
Eli Lilly and Company (LLY) is traded on New York Stock Exchange in USA. It is located in INDIANA, U.S.A and employs 40,655 people. Eli Lilly is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with total capitalization of 84.11 B. Eli Lilly and Company runs under Healthcare
sector within Pharmaceuticals And Biosciences
industry. This company has 1.04 B outstanding shares of which 11.25 M shares are now shorted by investors with about 3.36 days to cover shorted positions.
LILLY ELI CO has about 8.03 B in cash with 5.62 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.65.
Check Eli Lilly Probability Of Bankruptcy